CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Hedia obtiene la aprobación para ampliar la atención digital de la diabetes a pacientes pediátricos

RegulatoryapprovedPositive
AI Analysis

Summary

Hedia received regulatory approval to expand its digital diabetes care platform to pediatric patients through an updated MDR certification, enabling enhanced insulin regimen support and expanded device connectivity.

Outcome Details

MDR certification updated to expand digital diabetes care to pediatric patients, enhance insulin regimen support, and expand device connectivity

Importance:6/10
Sentiment:
0.70
regulatory approvaldigital healthpediatricdiabetesMDR certification

Read the original article

Published by PR Newswire Pharma on September 22, 2026 8:00 AM

Read Original